Illumina Inc ILMN
News
Karina Katalina Moreno Is Living Her Dream
Monitoring the Health of Our World's Oceans
European Court of Justice rules in favor of Illumina in jurisdictional appeal
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
Illumina announces strategy to accelerate value creation
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2024
Illumina launches new oncology menu for NovaSeq X Series customers
How Employees Make a Difference at Illumina
Illumina to Present Upcoming Strategy Update
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
Expanding Hope to More Families With Rare Diseases in China
Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base
CrowdStrike, KKR and GoDaddy to join S&P 500
Walt Disney Nominates 12 to Board of Directors, Says CEO Iger's Compensation Doubled in 2023
Illumina to sell cancer-test maker Grail after latest antitrust ruling
Illumina Submits SEC Form For Grail Divestiture
As Illumina stock bounces off a 10-year low, analysts see no quick fix
Illumina's stock on track for lowest close in 10 years after cutting guidance